Molecular analysis of the role of the group a Streptococcal cysteine protease, hyaluronic acid capsule, and M protein in a murine model of human invasive soft-tissue infection

Journal of Clinical Investigation

Volumn 102, Issue 3, 1998, Pages 550-560

  Ashbaugh, Cameron D ^a,b,d   Warren, Henry B ^c   Carey, Vincent J ^a   Wessels, Michael R ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d CHANNING LABORATORY   (United States)

Author keywords

Necrotizing fasciitis; Streptococcus pyogenes; Virulence

Indexed keywords

BACTERIAL ENZYME; CYSTEINE PROTEINASE; HYALURONIC ACID; M PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL GENE; BACTERIAL VIRULENCE; CONTROLLED STUDY; HISTOPATHOLOGY; HOST RESISTANCE; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SOFT TISSUE INFECTION; STREPTOCOCCUS INFECTION;

EID: 0032145096     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI3065     Document Type: Article

References (43)

1. Davies, H.D., A. McGeer, B. Schwartz, K. Green, D. Cann, A.E. Simor, D.E. Low, and The Ontario Group A Streptococcal Study Group. 1996. Invasive group A streptococcal infections in Ontario, Canada. N. Engl. J. Med. 335: 547-554.
2. Cleary, P.P., E.L. Kaplan, J.P. Handley, A. Wlazlo, M.H. Kim, A.R. Hauser, and P.M. Schlievert. 1992. Clonal basis for resurgence of serious Streptococcus pyogenes disease in the 1980s. Lancet. 339:518-521.
3. Musser, J.M., V. Kapur, S. Kanjilal, U. Shah, D.M. Musher, N.L., Barg, K.H. Johnston, P.M. Schlievert, J. Henrichson, D. Gerlach, et al. 1993. Geographic and temporal distribution and molecular characterization of two highly pathogenic clones of Streptococcus pyogenes expressing allelic variants of pyrogenic exotoxin A (scarlet fever toxin). J. Infect. Dis. 167:337-346.
4. Chaussee, M.S., J. Liu, D.L. Stevens, and J.J. Ferretti. 1996. Genetic and phenotypic diversity among isolates of Streptococcus pyogenes from invasive infections. J. Infect. Dis. 173:901-908.
5. Cone, L.A., D.R. Woodard, P.M. Schlievert, and G.S. Tomory. 1987. Clinical and bacteriologic observations of a toxic shock-like syndrome due to Streptococcus pyogenes. N. Engl. J. Med. 317:146-149.
6. Stevens, D.L., M.H. Tanner, J. Winship, R. Swarts, K.M. Ries, P.M. Schlievert, and E. Kaplan. 1989. Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. N. Engl. J. Med. 321:1-8.
7. Burns, E.H.J., A.M. Marciel, and J.M. Musser. 1996. Activation of a 66-kilodalton human endothelial cell matrix metalloprotease by Streptococcus pyogenes extracellular cysteine protease. Infect. Immun. 64:4744-4750.
8. Musser, J.M., K. Stockbauer, V. Kapur, and G.W. Rudgers. 1996. Substitution of cysteine 192 in a highly conserved Streptococcus pyogenes extracellular protease (interleukin 1B convertase) alters proteolytic activity and ablates zymogen processing. Infect. Immun. 64:1913-1917.
9. Wheeler, M.C., M.H. Roe, E.L. Kaplan, P.M. Schlievert, and J.K. Todd. 1991. Outbreak of group A streptococcus septicemia in children. J. Am. Med. Assoc. 266:533-537.
10. Talkington, D.F., B. Schwartz, C.M. Black, J.K. Todd, J. Elliott, R.F. Breiman, and R.R. Facklam. 1993. Association of phenotypic and genotypic characteristics of invasive Streptococcus pyogenes isolates with clinical components of streptococcal toxic shock syndrome. Infect. Immun. 61:3369-3374.
11. Lukomski, S., S. Sreevatsan, C. Amberg, W. Reichardt, M. Woischnik, A. Podbielski, and J.M. Musser. 1997. Inactivation of Streptococcus pyogenes extracellular cysteine protease significantly decreases mouse lethality of serotype M3 and M49 strains. J. Clin. Invest. 99:2574-2580.
12. Lukomski, S., E.H.J. Burns, P.R. Wyde, A. Podbielski, J. Rurangirwa, D.K. Moore-Poveda, and J.M. Musser. 1998. Genetic inactivation of an extracellular cysteine protease (SpeB) expressed by Streptococcus pyogenes decreases resistance to phagocytosis and dissemination to organs. Infect. Immun. 66:771-776.
13. Wessels, M.R., A.E. Moses, J.B. Goldberg, and T.J. DiCesare. 1991. Hyaluronic acid capsule is a virulence factor for mucoid group A streptococci. Proc. Natl. Acad. Sci. USA. 88:8317-8321.
14. Wessels, M.R., J.B. Goldberg, A.E. Moses, and T.J. DiCesare. 1994. Effects on virulence of mutations in a locus essential for hyaluronic acid capsule expression in group A streptococci. Infect. Immun. 62:433-441.
15. Husmann, L.K., D.-L. Yung, S.K. Hollingshead, and J.R. Scott. 1997. Role of putative virulence factors of Streptococcus pyogenes in mouse models of long-term throat colonization and pneumonia. Infect. Immun. 65:1422-1430.
16. Schrager, H., and M.R. Wessels. 1996. Hyaluronic acid capsule and the role of streptococcal entry into keratinocytes in invasive skin infection. J. Clin. Invest. 98:1954-1958.
17. Lancefield, R. 1957. Differentiation of group A streptococci with a common R antigen into three serological types with special reference to the bactericidal test. J. Exp. Med. 107:525-544.
18. Perez-Casal, J., M.G. Caparon, and J.R. Scott. 1992. Introduction of the M6 gene into a deleted strain of Streptococcus pyogenes restores its ability to resist phagocytosis. Res. Microbiol. 143:549-558.
19. Lancefield, R.C. 1962. Current knowledge of the type specific M antigens of group A streptococci. J. Immunol. 89:307-313.
20. Hollingshead, S.K., J.W. Simecka, and S.M. Michalek. 1993. Role of M protein in pharyngeal colonization by group A streptococci in rats. Infect. Immun. 61:2277-2283.
21. Moses, A.E., M.R. Wessels, K. Zalcman, S.A. Alberti, S. Natanson-Yaron, T. Menes, and E. Hanski. 1997. Relative contributions of hyaluronic acid capsule and M protein to virulence in a mucoid strain of the group A streptococcus. Infect. Immun. 65:64-71.
22. Wexler, D.E., D.E. Chenoweth, and P.P. Cleary. 1985. Mechanism of action of the group A streptococcal C5a inactivator. Proc. Natl. Acad. Sci. USA. 82:8144-8148.
23. Cleary, P.P., U. Prahbu, J.B. Dale, D.E. Wexler, and J. Handley. 1992. Streptococcal C5a peptidase is a highly specific endopeptidase. Infect. Immun. 60:5219-5223.
24. Berge, A., and L. Bjorck. 1995. Streptococcal cysteine protease releases biologically active fragments of streptococcal surface proteins. J. Biol. Chem. 270:9862-9867.
25. Wang, R.F., and S.R. Kushner. 1991. Construction of versatile low-copy-number vectors for cloning, sequencing, and gene expression in Escherichia coli. Gene. 100:195-199.
26. Perez-Casal, J., J.A. Price, E. Maguin, and J.R. Scott. 1993. An M protein with a single C repeat prevents phagocytosis of Streptococcus pyogenes: use of a temperature-sensitive shuttle vector to deliver homologous sequences to the chromosome of S. pyogenes. Mol. Microbiol. 8:809-819.
27. Current Protocols in Molecular Biology. 1987. F.M. Ausubel, R. Brent, R.E. Kingston, D.D. Moore, J.G. Seidman, J.A. Smith, and K. Struhl, editors. J. Wiley, New York.
28. O'Connor, S.P., and P.P. Cleary. 1987. In vivo Streptococcus pyogenes C5a peptidase activity: analysis using transposon-and nitrosoguanidine-induced mutants. J. Infect. Dis. 156:495-504.
29. Caparon, M.G., D.S. Stephens, A. Olsen, and J.R. Scott. 1991. Role of M protein in adherence of group A streptococci. Infect. Immun. 59:1811-1817.
30. Caparon, M.G., and J.R. Scott. 1991. Genetic manipulation of pathogenic streptococci. Methods Enzymol. 204:556-586.
31. Hynes, W.L., and J.R. Tagg. 1985. A simple plate assay for detection of group A streptococcus proteinase. J. Microbiol. Methods. 4:25-31.
32. Lancefield, R.C. 1928. The antigenic complex of Streptococcus hemolyticus. I. Demonstration of a type specific substance in extracts of Streptococcus hemolyticus. J. Exp. Med. 47:91-103.
33. Laboratory Methods in Histotechnology. 1992. E.B. Prophet, B. Mills, J.B. Arrington, and L.H. Sobin, editors. American Registry of Pathology, Washington, D.C.
34. Statistical Models and Methods for Lifetime Data. 1982. J.F. Lawless, editor. J. Wiley, New York.
35. Hauser, A.R., and P.M. Schlievert. 1990. Nucleotide sequence of the streptococcal pyrogenic exotoxin type B gene and toxin relationship to streptococcal proteinase precursor. J. Bacteriol. 172:4536-4542.
36. Dougherty, B.A., and I. van de Rijn. 1994. Molecular characterization of hasA from an operon required for hyaluronic acid synthesis in group A streptococci. J. Biol. Chem. 269:169-175.
37. DeAngelis, P.L., J. Papaconstantinou, and P.H. Weigel. 1993. Molecular cloning identification, and sequence of the hyaluronan synthase gene from group A Streptococcus pyogenes. J. Biol. Chem. 268:19181-19184.
38. Dale, J.B., M. Simmons, E.C. Chiang, and E.Y. Chiang. 1996. Recombinant, octavalent group A streptococcal M protein vaccine. Vaccine. 14:944-948.
39. Barker, F.G., B.J. Leppard, and D.V. Seal. 1987. Streptococcal necrotizing fasciitis: comparison between historical and clinical features. J. Clin. Pathol. 40:335-341.
40. Crater, D.L., B.A. Dougherty, and I. van de Rijn. 1995. Molecular characterization of hasC from an operon required for hyaluronic acid synthesis in group A streptococci. J. Biol. Chem. 270:28676-28680.
41. Crater, D.L., and I. van de Rijn. 1995. Hyaluronic acid synthesis operon (has) expression in group A streptococci. J. Biol. Chem. 270:18542-18548.
42. Wessels, M.R., and M.S. Bronze. 1994. Critical role of the group A streptococcal capsule in pharyngeal colonization and infection in mice. Proc. Natl. Acad. Sci. USA. 91:12238-12242.
43. Ji, Y., L. McLandsborough, A. Kondagunta, and P.P. Cleary. 1996. C5a peptidase alters clearance and trafficking of group A streptococci by infected mice. Infect. Immun. 64:503-510.